Where Are They Now: Updates on 7 SPAC MergersWhere Are They Now: Updates on 7 SPAC Mergers

2021 was a breakout year for special purpose acquisition corporation mergers in medtech. A look at what these companies are up to now.

Omar Ford

January 20, 2022

7 Slides
IMG_2022-1-20-161026.jpg

Already have an account?

Andrii Yalanskyi / Alamy Stock Photo

2021 was a breakout year for special purpose acquisition corporation mergers in medtech. A look at what these companies are up to now.

Last year medtech jumped head-first into special purpose acquisition corporation mergers. Some of the bigger private companies in the industry went public via the SPAC route.  By far SPACs were one of medtech’s hottest trends.

MD+DI is taking a look at what these companies have accomplished since going public through a SPAC.

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like